Abstract
We present a case series describing the management and genetic findings in five neonates with meconium ileus, presenting within 48 h of birth. Whole-exome sequencing identified cystic fibrosis transmembrane conductance regulator mutations in three neonates, confirming cystic fibrosis, with one heterozygous variant of unknown significance. Two ultimately required surgical intervention after failed conservative management. One died of septic shock.
Introduction
Neonatal intestinal obstruction occurs in 1/1500 live births and represents the most common neonatal surgical emergency.1,2 Meconium ileus (MI) is one cause characterized by distal ileal obstruction from thickened and inspissated meconium. 3 Its exact incidence remains unknown. Cystic fibrosis (CF) is the underlying etiology in 80–90% of cases. 4 Despite this strong genetic association, diagnostic workup for MI in low- and middle-income countries (LMICs) primarily relies on radiological imaging, 5 with genetic screening often omitted from the standard investigation protocol. This practice potentially overlooks the significant information that could direct long-term management and prognosis.

Abdominal radiograph with GI contrast delineating of non-passage of the contrast enema beyond ileo-cecal valve.

Abdominal radiograph with GI contrast demonstrating microcolon (arrow) in a neonate with meconium ileus.
Case series
Details of clinical characteristics are shown in Table 1. Four were term neonates, and one a late preterm. All presented within 48 h of life with abdominal distension, bilious vomiting, and failure to pass meconium.
Clinical characteristics and investigation profile of neonates with MI.
CFTR: cystic fibrosis transmembrane conductance regulator; ICJ: ileo-cecal junction, NG: nasogastric; MI: meconium ileus; USG: ultrasonography.
Clinical examination revealed a tense abdomen, a patent anal opening, and absent or sluggish bowel sounds. Two neonates demonstrated echogenic bowel and dilated bowel loops on an antenatal ultrasound scan. Initial workup included abdominal radiography, ultrasonography, and contrast enema. All neonates had dilated bowel loops on radiography, with one showing tiny calcifications suggestive of a meconium pseudocyst, confirmed by ultrasonography. Gastro-intestinal contrast studies predominantly revealed the absence of contrast distal to the ileo-caecal junction (Fig. 1), with additional findings of microcolon (Fig. 2) and filling defects. Three presented as simple MI, and the remaining two had peritonitis.
Genetic testing by whole-exome sequencing was done in all five neonates; three had cystic fibrosis transmembrane conductance regulator (CFTR) mutations suggestive of CF, while one showed a heterozygous genetic abnormality of unknown significance.
Initially, the three neonates with simple MI were managed conservatively, which included warm saline bowel wash-outs followed by N-acetyl cysteine enema administration. Of these, two eventually required surgical intervention because of deterioration. At exploratory laparotomy, evacuation of viscous meconium followed by resection of necrotic segments and end-to-end anastomosis of intact bowel segments was performed.
The other two neonates with suggestion of peritonitis ab initio underwent exploratory laparotomy. One had adhesions secondary to meconium peritonitis and underwent adhesiolysis with peritoneal lavage with placement of drains in the pelvic and paracolic gutters as well as a defunctioning ileostomy. The other underwent evacuation of inspissated meconium by diluted Gastrograffin washout. An appendicectomy, T-tube placement at the junction of the ileum and the transitional point, was performed, and the tube brought out in the right lumbar region. However, a revision exploratory laparotomy needed to be done owing to non-passage of meconium despite conservative measures. The proximal ileal loop was re-constructed as an ileostomy, and a mucus fistula was brought out. Intra-operative rectal biopsies were performed in all cases but were not suggestive of aganglionosis.
Postoperatively, enteral nutrition was initiated after signs of functioning bowel appeared. Three of four neonates were started on pancreatic enzyme supplementation after assessing them for the same according to protocol. 6 Four neonates survived to discharge, while one succumbed to septic shock.
The diagnosis of CF by genetic testing helped guide nutritional support protocols (viz. more aggressive enzyme supplementation for patients with severe mutations and complicated presentation), as well as more frequent follow-up visits for assessment of growth, family counseling, and screening of siblings.
Discussion
MI is a surgical condition resulting from impaction of viscous meconium, obstructing the small intestine at the terminal ileum.7,8 While there is a strong correlation between CF and MI, other conditions such as intestinal atresia, Hirschsprung disease, and pancreatic abnormalities contribute to 15–20% of MI cases. 4 Simple MI is most often managed successfully by conservative management in 30–50% of cases, while complicated MI, associated with volvulus, necrosis, intestinal atresia, or perforation with meconium peritonitis, demands surgical intervention. 9 Antenatal genetic analysis is helpful and must be offered to pregnant women with a positive family history and prenatal foetal ultrasound findings, such as dilated and echogenic bowel. 10
Genetic analysis has emerged as a potential diagnostic tool, with specific CFTR mutations correlating with MI risk. Previous studies have demonstrated varying risk levels: high risk with the G542X mutation, moderate risk with ΔF508, and low risk with G551D. 11 A study from India identified notable differences in the CFTR genetic profiles and clinical manifestations of CF based on geographic location. The highly pathogenic CFTR variants, F508del and c.1029delC, were frequently observed in cases of infant and early childhood mortality. 12 Resource-limited settings with a high burden of CF might benefit from targeted gene panels. CF is linked to significant clinical morbidity, including severe protein-energy malnutrition, respiratory problems, high rates of Pseudomonas aeruginosa infections, and increased mortality. 13 LMICs with high CF incidence would benefit from early screening programmes to reduce preventable morbidity and mortality. Genetic analysis determines CFTR modulator eligibility and informs disease management, while establishing a CF registry is essential for documenting disease burden and improving neonatal screening infrastructure. 12
The small sample size represents a major limitation of our series. However, we can nonetheless present valuable insights into the presentation and management of MI in our specific population.
Footnotes
Author contributions
CA collected data about the cases, prepared the initial manuscript, and was involved in the clinical management of all the cases. PC collected all case details and images and was part of the team involved in case management. PS oversaw the manuscript and finalized the manuscript. SC, MP, and SB supervised the manuscript and monitored the information collection.
Declaration of conflicting interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
